![]() MAX BioPharma MAX BioPharma is a biopharmaceutical company developing small molecule lipids as candidates for therapeutic drugs. | ![]() BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. | ![]() Aptuit Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions. | Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | Boston Analytical Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing. | |
Founding Date | Founding Date 2011 | Founding Date 1986 | Founding Date 1993 | Founding Date 1975 | Founding Date 1987 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations HQ | Locations Durham, US HQ Hoover, US | Locations Greenwich, US HQ Verona, IT Reinach, CH Milton, GB | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES | Locations Salem, US HQ |
Employees | Employees 12 | Employees 14040% increase | Employees 761 | Employees 332 | Employees 2441% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $346.7m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods N/A | Cost of goods $190.3m (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit N/A | Gross profit $156.4m (FY, 2018) | Gross profit N/A |
Net income | Net income N/A | Net income $263.9m (FY, 2025) | Net income N/A | Net income $40.5m (FY, 2018) | Net income N/A |

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View company
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.
View companyBioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View companyBoston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing.
View company